Cardiac SOCS Proteins: A Role in Enterovirus Infection
Cardiac SOCS Proteins: A Role in Enterovirus Infection
批准号:
7237297
负责人:
Kirk U Knowlton
金额:
$21.62万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-05 至 2009-04-30
关键词:
AddressAdultAffectAntiviral AgentsAntiviral ResponseBindingCardiacCardiac MyocytesCardiomyopathiesChildComplexCoxsackie VirusesCytokine Inducible SH2-Containing ProteinCytokine Network PathwayDataDilated CardiomyopathyDiseaseDisruptionDissectionEnterovirus InfectionsFamilyGlycoproteinsGoalsGrowth and Development functionHeartHeart DiseasesHeart failureHost DefenseImmuneImmune responseInfectionInterferon Type IIInterferonsInterleukin-6Janus kinaseKnock-outMediatingMediator of activation proteinMusPathogenesisPathogenicityPublishingRoleSTAT proteinSignal InductionSignal TransductionSignaling ProteinStimulusTransgenic MiceTransgenic OrganismsTyrosine PhosphorylationViralVirus DiseasesVirus Inhibitorscardiotrophin 1cytokinecytokine receptor gp130designinhibitor/antagonistinsightinterferon alpha receptorinterferon alpha-beta receptorinterferon gamma receptorinterferon gamma receptorsleukemia inhibitory factor receptornovelnovel therapeuticsreceptorresponsetherapeutic target
中文摘要
描述(申请人提供):心脏的柯萨奇病毒感染是导致儿童和成人心肌病的重要原因。然而,对心肌细胞内控制病毒感染的固有信号机制知之甚少。对这些机制的更好理解可能有助于设计新的病毒性心脏病治疗策略。最近,我们发现SOCS-1的表达抑制了心肌细胞JAK信号转导和转录激活因子(STAT)的表达,对病毒复制和病毒介导的细胞病变有显著影响。干扰素α/β受体的破坏对心脏早期病毒复制没有影响,干扰素-伽马受体的破坏对早期病毒复制的影响很小。因此,我们假设其他非干扰素介导的先天性免疫机制在心肌细胞内对抗病毒感染是重要的。这些可能包括通过糖蛋白(GP)130发出的信号,该信号也能激活JAK-STAT信号。因此,我们提出了以下具体目标:1)在CVB3感染的小鼠中,确定gp130信号和/或干扰素-γ信号对于a)在心脏中诱导JAK-STAT-SoCs信号和b)针对病毒感染的先天性免疫防御是重要的。2)明确病毒感染和复制的相关机制,通过在心肌细胞中强制表达SOCS1来诱导CVB3感染后显著的细胞病变效应,并确定转基因SOCS3表达是否也会以类似于SOCS1转基因小鼠的方式影响先天免疫反应。3)确定心脏特异的SOCS1和SOCS3基因敲除对心肌细胞JAK-STAT信号的影响以及与CVB3感染相关的心肌病。这些目的将为心肌细胞内JAK-STAT-SOC激活调节先天抗病毒反应的机制提供新的见解。
英文摘要
DESCRIPTION (provided by applicant): Coxsackieviral infection of the heart is an important cause of cardiomyopathy in children and adults. However, little is known of the innate signaling mechanisms within the cardiac myocytes that control viral infection. A better understanding of these mechanisms may allow design of novel therapeutic strategies for viral heart disease. Recently, we have shown that inhibition of Janus kinase (JAK)- signaling transducer and activator of transcription (STAT) in the cardiac myocyte by expression of SOCS 1 has a marked effect on viral replication and viral-mediated cytopathic effects. Disruption of interferon alpha/beta receptors had no effect and disruption of interferon-gamma receptors had minimal effect on early viral replication in the heart. We, therefore, hypothesize that other, non-interferon mediated innate immune mechanisms are important within the cardiac myocyte to combat viral infection. These could include signaling through the glycoprotein (gp) 130 that also activates JAK-STAT signaling. We, therefore, propose the following specific aims: 1) Determine in CVB3 infected mice whether gp130, IFN-gamma signaling, or both are important for a) the induction of JAK-STAT-SOCS signaling in the heart and b) the innate immune defense against viral infection. 2) Identify mechanisms related to viral infection and replication by which forced expression of SOCS1 in the cardiac myocyte induces a marked cytopathic effect following CVB3 infection and determine whether transgenic SOCS3 expression will also affect the innate immune response in a manner similar to that observed in SOCS1 transgenic mice. 3) Determine the effect of cardiac-specific knockout of SOCS1 and SOCS3 on JAK-STAT signaling in cardiac myocytes and the cardiomyopathy associated with CVB3 infection. These aims will provide a novel insight into the mechanisms by which JAK-STAT-SOCS activation within the cardiac myocyte regulates the innate anti-viral response.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication.
柯萨奇病毒 B3 的心脏选择性感染需要完整的 I 型干扰素信号传导:对死亡率和早期病毒复制的影响。
DOI:
10.1161/01.cir.103.5.756
发表时间:
2001
期刊:
Circulation
影响因子:
37.8
作者:
[Wessely,R, Klingel,K, Knowlton,KU, Kandolf,R]
通讯作者:
Kandolf,R
Enteroviral cardiomyopathy: bad news for the dystrophin-glycoprotein complex.
肠道病毒心肌病:抗肌萎缩蛋白-糖蛋白复合物的坏消息。
DOI:
10.1007/s000590050011
发表时间:
2000
期刊:
Herz.
影响因子:
--
作者:
[Badorff,C, Lee,GH, Knowlton,KU]
通讯作者:
Knowlton,KU
Dissociation of sarcoglycans and the dystrophin carboxyl terminus from the sarcolemma in enteroviral cardiomyopathy.
肠道病毒性心肌病中肌聚糖和肌营养不良蛋白羧基末端从肌膜解离。
DOI:
10.1161/01.res.87.6.489
发表时间:
2000
期刊:
Circulation research
影响因子:
20.1
作者:
[Lee,GH, Badorff,C, Knowlton,KU]
通讯作者:
Knowlton,KU
Adhesion Molecules of the Intercalated Disc in Cardiomyopathy
-
批准号:7905098
-
项目类别:
-
资助金额:$31.07万
-
财政年份:2009
-
负责人:Kirk U Knowlton
-
依托单位:
Administative Core
-
批准号:7905104
-
项目类别:
-
资助金额:$31.07万
-
财政年份:2009
-
负责人:Kirk U Knowlton
-
依托单位:
Adhesion Molecules of the Intercalated Disc in Cardiomyopathy
-
批准号:7331346
-
项目类别:
-
资助金额:$62.08万
-
财政年份:2007
-
负责人:Kirk U Knowlton
-
依托单位:
Administative Core
-
批准号:7331360
-
项目类别:
-
资助金额:$5.16万
-
财政年份:2007
-
负责人:Kirk U Knowlton
-
依托单位:
Biomechanical Stress Pathways and Cardiomyopathy
-
批准号:7288521
-
项目类别:
-
资助金额:$52.27万
-
财政年份:2005
-
负责人:Kirk U Knowlton
-
依托单位:
Role of mTOR, a Component of the Akt Pathway, in Regulating Cardiac Function
-
批准号:8386980
-
项目类别:
-
资助金额:$35.99万
-
财政年份:2005
-
负责人:Kirk U Knowlton
-
依托单位:
CORE--MYOCARDIAL CELL BIOLOGY AND VIRAL VECTOR FACILITY
-
批准号:7098691
-
项目类别:
-
资助金额:$15.69万
-
财政年份:2005
-
负责人:Kirk U Knowlton
-
依托单位:
Dystrophin-glyoprotein complex and dilated cardiomyopathy
-
批准号:6564971
-
项目类别:
-
资助金额:$13.92万
-
财政年份:2002
-
负责人:Kirk U Knowlton
-
依托单位:
CORE--CELL BIOLOGY AND VIRAL VECTOR FACILITY
-
批准号:6651374
-
项目类别:
-
资助金额:$10.66万
-
财政年份:2002
-
负责人:Kirk U Knowlton
-
依托单位:
Dystrophin-glycoprotein complex in viral cardiomyopathy
-
批准号:6382595
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2001
-
负责人:Kirk U Knowlton
-
依托单位:
Dystrophin-glycoprotein complex in viral cardiomyopathy
-
批准号:6537944
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2001
-
负责人:Kirk U Knowlton
-
依托单位:
Dystrophin-glycoprotein complex in viral cardiomyopathy
-
批准号:6755170
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2001
-
负责人:Kirk U Knowlton
-
依托单位:
Dystrophin-glycoprotein complex in viral cardiomyopathy
-
批准号:6603289
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2001
-
负责人:Kirk U Knowlton
-
依托单位:
Dystrophin-glyoprotein complex and dilated cardiomyopathy
-
批准号:6424548
-
项目类别:
-
资助金额:$13.92万
-
财政年份:2001
-
负责人:Kirk U Knowlton
-
依托单位:
Molecular Pathways for Hypertrophy and Cardiomyopathy
-
批准号:7905105
-
项目类别:
-
资助金额:$217.5万
-
财政年份:1998
-
负责人:Kirk U Knowlton
-
依托单位:
MYOCYTE APOPTOSIS AND A TRANSGENIC HEART FAILURE MODEL
-
批准号:2759121
-
项目类别:
-
资助金额:$17.72万
-
财政年份:1998
-
负责人:Kirk U Knowlton
-
依托单位:
MYOCYTE APOPTOSIS AND A TRANSGENIC HEART FAILURE MODEL
-
批准号:6330114
-
项目类别:
-
资助金额:$18.13万
-
财政年份:1998
-
负责人:Kirk U Knowlton
-
依托单位:
Cardiac SOCS Proteins: A Role in Enterovirus Infection
-
批准号:6775967
-
项目类别:
-
资助金额:$22.8万
-
财政年份:1998
-
负责人:Kirk U Knowlton
-
依托单位:
Molecular Pathways for Hypertrophy and Cardiomyopathy
-
批准号:7644910
-
项目类别:
-
资助金额:$217.5万
-
财政年份:1998
-
负责人:Kirk U Knowlton
-
依托单位:
MYOCYTE APOPTOSIS AND A TRANSGENIC HEART FAILURE MODEL
-
批准号:6125819
-
项目类别:
-
资助金额:$17.6万
-
财政年份:1998
-
负责人:Kirk U Knowlton
-
依托单位:
海外基金